Universities in Nottingham to play a key role in the development of a potential DNA vaccine against COVID-19

“As the COVID-19 pandemic has unfolded, Scancell has been evaluating how it can best contribute its expertise and resources to help in the global response. Vaccines are the long-term solution and we believe our approach has the potential to produce a second-generation vaccine that will generate an effective and durable immune response to COVID-19.”